[Federal Register Volume 89, Number 187 (Thursday, September 26, 2024)]
[Notices]
[Pages 78874-78875]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-21981]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-24-24HP]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled ``Compliance Attestation Statement for the 
Framework for Nucleic Acid Synthesis Screening'' to the Office of 
Management and Budget (OMB) for review and approval. CDC previously 
published a ``Proposed Data Collection Submitted for Public Comment and 
Recommendations'' notice on July 24, 2024 to obtain comments from the 
public and affected agencies. CDC did not receive comments related to 
the previous notice. This notice serves to allow an additional 30 days 
for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct 
written comments and/or suggestions regarding the items contained in 
this notice to the Attention: CDC Desk Officer, Office of Management 
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    Compliance Attestation Statement for the Framework for Nucleic Acid 
Synthesis Screening--New--Office of Science (OS), Centers for Disease 
Control and Prevention (CDC).

Background and Brief Description

    The purpose of this Attestation Form is to assist providers of 
synthetic nucleic acids (Providers) and manufacturers of benchtop 
nucleic acid synthesis equipment (Manufacturers) in making an 
attestation that they are performing due diligence in screening product 
orders and customers consistent with the expectations outlaid in the 
federal Framework for Nucleic Acid Synthesis Screening (Framework). 
While Providers and Manufacturers may choose a different mode to make 
such an attestation, this Attestation Form serves as a valid template. 
This statement of attestation will provide the U.S. Federal Government 
and researchers using any United States Government life sciences 
research award (e.g., research grant, contract, etc.) for procurement 
of synthetic nucleic acids or benchtop nucleic acid synthesis equipment 
reasonable assurance that Providers and Manufacturers are complying 
with the Framework.
    CDC requests OMB approval for an estimated 20 annual burden hours. 
There are no costs to respondents other than their time to participate.

Estimated Annualized Burden Hours

----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
Providers and manufacturers of          Annual Provider and                   60               1           20/60
 synthetic nucleic acids and bench top   Manufacturer Self-
 nucleic acid synthesis equipment.       Attestation Statement.
----------------------------------------------------------------------------------------------------------------



[[Page 78875]]

Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Public Health 
Ethics and Regulations, Office of Science, Centers for Disease Control 
and Prevention.
[FR Doc. 2024-21981 Filed 9-25-24; 8:45 am]
BILLING CODE 4163-18-P